Eterna Therapeutics
ERNA
7 hedge funds and large institutions have $7.92M invested in Eterna Therapeutics in 2014 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
30% more capital invested
Capital invested by funds: $6.1M → $7.92M (+$1.82M)
0% more funds holding
Funds holding: 7 → 7 (0)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$44K |
| 2 |
CL
CSS LLC
Chicago,
Illinois
|
-$6K |
ERNA Hedge Fund Activity: Q4 2014 in Review
7 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q4 2014, worth a combined $7.92M — up 30% from $6.1M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ERNA positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest seller was Dimensional Fund Advisors, cutting an estimated $44K.
- 7 institutional investors held Eterna Therapeutics (ERNA) as of Q4 2014, unchanged from Q3 2014.
- Funds reported $7.92M of Eterna Therapeutics stock for Q4 2014, up 30% quarter-over-quarter.
- 1 fund opened new Eterna Therapeutics positions in Q4 2014 and 0 closed out, a net change of +1 holder.
- The largest Eterna Therapeutics seller in Q4 2014 was Dimensional Fund Advisors, an estimated $44K sold.
Based on aggregated 13F filings for Q4 2014.